Attention should be paid to the supply guarantee of anticancer drugs entering the "fast lane" with price reduction

[market analysis of chinapharma.com] on August 28, Shaanxi Province issued the notice on negotiation of price reduction of anticancer drugs by some countries, which adjusted the prices of anticancer drugs being implemented in the platform If there is no objection, the adjusted purchase prices will be implemented from September 1 Eight countries that announced the price adjustment negotiated anti-cancer drugs, with an average decrease of 4.69% in eight products Among them, there are three products with a drop of more than 6%, and the other five products have a drop of 3%~5% It is understood that although cancer research has made a lot of progress in recent years, the incidence of cancer is still rapid According to statistics, in 2016 alone, there were 17.2 million cancer cases worldwide, resulting in 8.9 million deaths Cancer has become an important "killer" of human beings Therefore, it is urgent to strengthen the research and development of cancer drugs I have learned that China is making continuous efforts to let more cancer patients use cheap and good drugs, and since 2018, the price of anti-cancer drugs has become the focus of social attention Shaanxi Province issued the notice on the price reduction of anticancer drugs, which is good news for cancer patients Under the background of "price reduction of anticancer drugs", drug procurement platforms in many parts of the country have started to issue documents asking for price reduction of some anticancer drugs It is reported that eight provinces across the country have issued documents asking for drug price reduction after the National Health Insurance Bureau asked for further price reduction of anticancer drugs that entered the medical insurance through drug price negotiation According to the industry, since the adjustment of China's anti-cancer drug tax policy in May this year, the price reduction of anti-cancer drugs has entered the "fast lane" In addition, with a new round of anti-cancer medical insurance access negotiations, more and more "sky high" anti-cancer drugs will be reduced through entering the medical insurance in the future With the incidence rate of cancer increasing year by year, the cancer drug "Hai Tao" and "purchasing" have become the high-frequency words On the one hand, patients are eager to use new and good drugs On the other hand, the high cost of medicine is prohibitive In order to help cancer patients who are "saving lives with equal drugs" to break through the dilemma of "expensive drugs", in recent years, the relevant departments of the state have played a series of combined boxing in promoting the price reduction of anti-cancer drugs, including anti-cancer drug tax reduction, medical insurance negotiation, drug centralized bidding and procurement These measures have brought many benefits to patients It is understood that at present, provincial-level anti-cancer drug special centralized procurement is being deployed in various regions Some leading places also actively explore regional alliance centralized procurement, enlarge the market, and encourage enterprises to reduce prices Up to now, Shaanxi, Guangxi, Jiangxi, Hainan, Henan, Guangdong, Hunan, Hubei, Sichuan, Shandong and other 15 provinces and cities have issued relevant documents to promote the price reduction of anticancer drugs At present, some enterprises have taken the initiative to reduce the price of some drugs, and some online drug prices have been reduced on drug purchase platforms in Gansu, Hubei and other places For example, a pharmaceutical company recently received a survey from an institution, saying that with the implementation of the follow-up measures to reduce the tax on anticancer drugs by the National Medical Security Bureau and other relevant departments, and the promotion of the price reduction of anticancer drugs, the company actively cooperated and promised to adjust the online prices of each province of ektini at the end of July Before September 1, 2018, the company will apply to all provincial drug bidding and purchasing departments to adjust the price of exetane online The adjusted price will be valid until December 31, 2019 The price reduction of anticancer drugs has brought good news to patients, but some experts pointed out that after the price reduction, how to guarantee the supply of drugs is also an important part of social concern According to the industry, before the price reduction of some "sky high" anticancer drugs, the drug popularization population may only be a few rich people, but after the price reduction and medical insurance, the drug users may show explosive growth, and under the premise that the production capacity of drug companies has not been improved, there may be a situation where the drug supply is in short supply Therefore, the state should take effective measures to solve this passive situation.